Science, asked by sumitjoshi12345xdk, 10 months ago

What role W.H.O is playing in the current scenario when the world faces the COVID – 19 pandemic?

Answers

Answered by pampaduttakundu
1

Answer:

Research works are carried out at WHO to discover about vaccines amd to get relieved from covid 19.

Plzz mark as brainliest if it is helpful to you

Answered by patangemahesh2013
0

ID-19)

Updated 17 June 2020

©

Summary

On 29 June 2020, WHO published a timeline as a definitive record of significant WHO activities, starting on 31 December 2019. It replaces an April version.

Rolling Updates continue to feature selected news items.

Follow @DrTedros and @WHO on Twitter, read WHO’s daily situation reports and news releases and watch our regular press conferences.

Hydroxychloroquine arm of Solidarity Trial stops

17 June 2020

WHO announced that the hydroxychloroquine (HCQ) arm of the Solidarity Trial to find an effective COVID-19 treatment was being stopped.

The trial's Executive Group and principal investigators made the decision based on evidence from the Solidarity trial, UK's Recovery trial and a Cochrane review of other evidence on hydroxychloroquine.

Data from Solidarity (including the French Discovery trial data) and the recently announced results from the UK's Recovery trial both showed that hydroxychloroquine does not result in the reduction of mortality of hospitalised COVID-19 patients, when compared with standard of care.

Investigators will not randomize further patients to hydroxychloroquine in the Solidarity trial. Patients who have already started hydroxychloroquine but who have not yet finished their course in the trial may complete their course or stop at the discretion of the supervising physician.

This decision applies only to the conduct of the Solidarity trial and does not apply to the use or evaluation of hydroxychloroquine in pre or post-exposure prophylaxis in patients exposed to COVID-19.

Key materials:

WHO Director-General's opening remarks at the media briefing on COVID-19 - 17 June 2020

Solidarity trial webpage

WHO welcomes preliminary results about dexamethasone use in treating critically ill COVID-19 patients

16 June 2020

WHO welcomes the initial clinical trial results from the UK that show dexamethasone, a corticosteroid, can be lifesaving for patients who are critically ill with COVID-19. For patients on ventilators, the treatment was shown to reduce mortality by about one third, and for patients requiring only oxygen, mortality was cut by about one fifth, according to preliminary findings shared with WHO.

Similar questions
Math, 10 months ago